New BGU Study: Medical Cannabis Reduces Blood Pressure
"Cannabis research is in its early stages and BGU is at the forefront of evaluating clinical use based on scientific studies," says Doug Seserman.
Historic Collaboration Between BGU and Morocco’s UIR
The collaboration between the Israeli and Moroccan universities will include the study of the Moroccan Jews’ cultural heritage, as well as the intertwined destiny of Jews and Muslims in the MENA (Middle East and North Africa) region.
A University With the Potential to Change All of Israel
“We are partnering in the remarkable, which is modern Israel as manifest through a university," says Doug Seserman, Chief Executive Officer of Americans for Ben-Gurion University. "BGU is driving the country forward.”
BGU Researchers Announce New Model for COVID-19 Policy Decisions
“Beyond Israel, this model could also help us in the United States as we work towards improving upon pandemic response strategies, reducing hospitalizations and saving lives,” says Americans for Ben-Gurion University CEO Doug Seserman.
BGU Study Finds Corals Are Able to Fight Infection
The findings are important to better understand how reef-building corals and other reef animals protect themselves from foreign invaders.
Twitter Study Reveals Significant COVID Emotional Impact
BGU researchers conducted the largest social media study to track emotional changes and discourse during the COVID-19 pandemic.
Forbes: Unprecedented Shark Discovery by BGU Researchers
One of the most significant discoveries of marine habitats in Israel’s history sheds light on the world’s understanding of climate change.
New Historic Academic Partnership Between Israel and Morocco
“This historic collaboration between BGU and UM6P is an exciting step towards bridge-building between Israel and Morocco," says Doug Seserman, chief executive officer of Americans for Ben-Gurion University.
COVID Vaccines Are Working
BGU Prof. Nadav Davidovitch, director of the School of Public Health, says those who are vaccinated are protected five to 10 times as much as those who are unable or unwilling to receive the shot.